We are live on ! Find out more
MBIO icon

Mustang Bio
MBIO

73 hedge funds and large institutions have $45.9M invested in Mustang Bio in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 10

143% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 7

91% more capital invested

Capital invested by funds: $24M → $45.9M (+$21.9M)

14% more funds holding

Funds holding: 64 → 73 (+9)

0.01% more ownership

Funds ownership: 0.03% → 0.04% (+0.01%)

56% less call options, than puts

Call options by funds: $147K | Put options by funds: $334K

Holders
73
Holders Change
+9
Holders Change %
+14.06%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
27
Reduced
10
Closed
7
Calls
$147K
Puts
$334K
Net Calls
-$187K
Net Calls Change
-$65K

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$6M
2
ECM
Endurant Capital Management
California
+$2.4M
3
Millennium Management
Millennium Management
New York
+$2.38M
4
SSA
Schonfeld Strategic Advisors
New York
+$1.21M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$1.16M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$675K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$281K
3
Renaissance Technologies
Renaissance Technologies
New York
-$217K
4
BlackRock
BlackRock
New York
-$70.1K
5
Simplex Trading
Simplex Trading
Illinois
-$65.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
SPC
26
Sigma Planning Corp
Michigan
$338K +$332K +142 New
Los Angeles Capital Management
27
Los Angeles Capital Management
California
$296K +$126K +54 +77%
Arrowstreet Capital
28
Arrowstreet Capital
Massachusetts
$249K +$243K +104 New
Charles Schwab
29
Charles Schwab
California
$243K +$18.7K +8 +9%
DC
30
Davenport & Co
Virginia
$240K – – –
N
31
Nuveen
North Carolina
$233K -$30.4K -13 -12%
Morgan Stanley
32
Morgan Stanley
New York
$232K +$16.4K +7 +8%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$203K +$67.8K +29 +52%
BFM
34
Boothbay Fund Management
New York
$172K – – –
Squarepoint
35
Squarepoint
New York
$164K -$58.5K -25 -27%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$138K – – –
Acadian Asset Management
37
Acadian Asset Management
Massachusetts
$137K -$281K -120 -68%
Wells Fargo
38
Wells Fargo
California
$136K +$23.4K +10 +21%
GCP
39
GSA Capital Partners
United Kingdom
$135K +$2.34K +1 +2%
Citadel Advisors
40
Citadel Advisors
Florida
$112K -$7.01K -3 -6%
QOP
41
Quinn Opportunity Partners
Virginia
$108K – – –
Lido Advisors
42
Lido Advisors
California
$105K – – –
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$100K +$7.01K +3 +8%
AllianceBernstein
44
AllianceBernstein
Tennessee
$99K +$98.2K +42 New
MIH
45
Meitav Investment House
Israel
$95K +$93.5K +40 New
CSS
46
Cubist Systematic Strategies
Connecticut
$83K +$81.8K +35 New
UBS Group
47
UBS Group
Switzerland
$70K +$14K +6 +26%
AIG
48
American International Group
New York
$56K +$2.34K +1 +5%
LI
49
Leap Investments
Illinois
$55K +$53.8K +23 New
AG
50
Algert Global
California
$53K -$23.4K -10 -31%
1
2
3 4

MBIO Hedge Fund Activity: Q2 2020 in Review

73 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2020, worth a combined $45.9M — up 91% from $24M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new MBIO positions and 7 closed out — a net gain of 10 holders — while 27 added to existing stakes and 10 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $6M. The largest seller was OrbiMed, exiting entirely with an estimated $675K sold.

  • 73 institutional investors held Mustang Bio (MBIO) as of Q2 2020, up from 64 in Q1 2020.
  • Funds reported $45.9M of Mustang Bio stock for Q2 2020, up 91% quarter-over-quarter.
  • 17 funds opened new Mustang Bio positions in Q2 2020 and 7 closed out, a net change of +10 holders.
  • The largest Mustang Bio buyer in Q2 2020 was JP Morgan Chase, an estimated $6M added.
  • The largest Mustang Bio seller in Q2 2020 was OrbiMed, an estimated $675K sold.

Based on aggregated 13F filings for Q2 2020.